LIFECORE BIOMEDICAL, INC. Payments to Acquire Businesses, Gross
LIFECORE BIOMEDICAL, INC. (LFCR) reported Payments to Acquire Businesses, Gross of $59.87 million for the 9-month period ending 2019-02-24, per its 10-Q filed 2019-04-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2019-04-04
- LIFECORE BIOMEDICAL, INC. payments to acquire businesses, gross for fiscal 2017 was $2.50M.
- LIFECORE BIOMEDICAL, INC. payments to acquire businesses, gross for fiscal 2012 was $66.83M.
| Period end | Payments to Acquire Businesses, Gross 0 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|
| 2019-02-24 | $59.87M 10-Q · filed 2019-04-04 | ||
| 2018-02-25 | $0.00 10-Q · filed 2019-04-04 | ||
| 2017-05-28 | $2.50M 10-K · filed 2018-08-09 | ||
| 2012-08-23 | $62.90M 10-Q · filed 2014-03-28 | ||
| 2012-05-27 | $66.83M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |